Published in N Engl J Med on November 16, 1995
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry (1996) 2.30
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science (1976) 1.76
DNA-triplet repeats and neurologic disease. N Engl J Med (1996) 1.60
Competent patients with advanced states of permanent paralysis have the right to forgo life-sustaining therapy. Neurology (1993) 1.58
Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology (1967) 1.50
Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord (2004) 1.48
Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med (1982) 1.31
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A (1981) 1.28
Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology (1976) 1.27
Markers for gene expression in cultured cells from the nervous system. J Biol Chem (1972) 1.26
Transverse myelitis associated with heroin addiction. JAMA (1968) 1.22
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology (1995) 1.21
Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol (2001) 1.20
Apoptosis and neurologic disease. Am J Med (2000) 1.17
Mononeuritis multiplex in lepromatous leprosy. Arch Neurol (1968) 1.12
Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology (1971) 1.07
Platelet APP isoform ratios correlate with declining cognition in AD. Neurology (2000) 1.01
Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol (1974) 1.01
Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol (2001) 1.00
Neurological complications of fibrous dysplasia of the skull. Arch Neurol (1968) 0.99
Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol (1978) 0.97
The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97
Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol (1978) 0.97
Glial tumor metastases through a ventriculo-pleural shunt. Resultant massive pleural effusion. Arch Neurol (1968) 0.94
The Machado-Joseph disease locus is different from the spinocerebellar ataxia locus (SCA1). Genomics (1992) 0.94
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry (1999) 0.91
Joseph disease: an autosomal dominant motor system degeneration. Adv Neurol (1984) 0.90
Progressive ophthalmoplegia. Report of cases. Arch Neurol (1968) 0.90
Prion proteins: a biological role beyond prion diseases. Acta Neurol Scand (2007) 0.90
Differences in the distribution of poly(A) size classes in individual messenger RNAs from neuroblastoma cells. J Biol Chem (1979) 0.89
Physiology of glia: glial-neuronal interactions. Int Rev Neurobiol (1979) 0.88
Frontal lobe ataxia. Surg Neurol (1995) 0.87
Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol (1975) 0.86
A radioisotopic, chromatographic microassay for acetyl-coenzyme A synthetase and some preliminary studies on the rat brain enzyme. Biochim Biophys Acta (1973) 0.85
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology (2003) 0.85
Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology (1997) 0.84
Induction of adenosine 3',5'-monophosphate binding proteins by N6,O2'-dibutyryladenosine 3',5'-monophosphate in mouse neuroblastoma cells. Analysis by two-dimensional gel electrophoresis. Biochemistry (1979) 0.84
Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures. J Neurol Sci (1997) 0.84
Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology (1987) 0.83
Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology (1978) 0.83
Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. J Med Genet (1995) 0.82
Regulation of the synthesis of choline-O-acetyltransferase and thymidylate synthetase in mouse neuroblastoma in cell culture. Proc Natl Acad Sci U S A (1971) 0.82
Specific messenger RNA changes in Joseph disease cerebella. Ann Neurol (1983) 0.82
Quantitation and characterisation of poly(A)-containing messenger RNAs from mouse neuroblastoma cells. Biochim Biophys Acta (1977) 0.81
Altered thymidine kinase or thymidylate synthetase activities in 5-fluoro deoxyuridine resistant variants of mouse neuroblastoma. J Neurochem (1977) 0.81
Furosemide-sensitive K+ channel in glioma cells but not neuroblastoma cells in culture. Biochem Biophys Res Commun (1982) 0.81
Reye's syndrome: isolation of parainfluenza virus. Report of three cases. Arch Neurol (1973) 0.81
Hypothermia and persisting capacity to develop fever. Occurrence in a patient with sarcoidosis of the central nervous system. Arch Neurol (1977) 0.81
Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum. IgG and IgM immunoglobulin studies. Neurology (1975) 0.81
A comparison of thymidylate synthetase activities from 5-fluorodeoxyuridine sensitive and resistant variants of mouse neuroblastoma. J Neurochem (1975) 0.81
Induction of cyclic AMP-binding proteins by dibutyryl cyclic AMP in mouse neuroblastoma cells. Biochim Biophys Acta (1978) 0.80
Joseph disease and Huntington disease: protein patterns in fibroblasts and brain. Neurology (1981) 0.80
An AP-2 binding sequence within exon 1 of human and porcine choline acetyltransferase genes enhances transcription in neural cells. Neuroscience (1997) 0.80
Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture. Mol Pharmacol (1974) 0.79
alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings. Neurology (1976) 0.79
Sleep apnea and hypoventilation syndrome associated with acquired nonprogressive dysautonomia: clinical and pathological studies in a child. Ann Neurol (1981) 0.79
Molecular genetics, recombinant DNA techniques, and genetic neurological disease. Ann Neurol (1984) 0.79
Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical? J Neuropsychiatry Clin Neurosci (1993) 0.79
Molecular neurogenetics: the genome is settling the issue. JAMA (1997) 0.78
Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities. J Pharmacol Exp Ther (1975) 0.78
Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. J Clin Endocrinol Metab (1978) 0.78
Amplification signals anticipation--less DNA is better. Neurology (1992) 0.78
Comparison of the CERAD and CVLT list-learning tasks in Alzheimer's disease. Clin Neuropsychol (2000) 0.78
Recombinant DNA and neurologic disease: the coming of a new age. Neurology (1983) 0.78
Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus. Hum Genet (1994) 0.77
Erroneous diagnosis corrected after 28 years. Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy. Arch Neurol (1996) 0.76
The 1990s--decade of the brain: the need for a national priority. Neurology (1990) 0.76
Neurotherapeutics, evidence-based neurology, and clinical equipoise. Arch Neurol (1999) 0.76
Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist (1998) 0.76
Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation. J Neurol Sci (2001) 0.76
Urine vapor pattern for olivopontocerebellar degeneration. Clin Biochem (1975) 0.76
Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J Neurosci Res (1991) 0.76
Memory loss--when is it Alzheimer disease? JAMA (1998) 0.76
Genomic neurology: a new beginning. Arch Neurol (2001) 0.76
Morphological differentiation and proteoglycan synthesis regulate Alzheimer amyloid precursor protein processing in PC-12 and human astrocyte cultures. J Neurosci Res (1992) 0.76
Idiopathic acute symmetrical polyradiculoneuritis. The Landry-Guillain-Barré-Strohl syndrome. West J Med (1974) 0.75
Presidential judgment. The twenty-fifth amendment. Arch Neurol (1997) 0.75
Defining the neurological basis of the Gulf War syndrome. Arch Neurol (2000) 0.75
Effect of norepinephrine on glucose metabolism in glioblastoma and neuroblastoma cells in cell culture. Proc Natl Acad Sci U S A (1972) 0.75
Treatment of cerebral edema. Calif Med (1971) 0.75
An anonymous single copy clone (p1,2-2) from a flow sorted human chromosomes 1 and 2 library (D1S33). Nucleic Acids Res (1987) 0.75
The triumph of linkage analysis. Ann Neurol (1990) 0.75
At jeopardy: the NIH as we know it. J Neurol Sci (2003) 0.75
Reporting clinical trials: full access to all the data. Stroke (2001) 0.75
Kinetics of acetylcholine synthesis and hydrolysis in myasthenia gravis. Science (1971) 0.75
The interrelationship of neurofibromatosis and fibrous dysplasia. Arch Neurol (1967) 0.75
Mononeuritis multiplex in lepromatous leprosy. Neurology (1968) 0.75
Thermolability in Wernicke's encephalopathy. Arch Neurol (1978) 0.75
Reporting clinical trials: full access to all the data. Neurology (2002) 0.75
Neuro-oncology 1999. Arch Neurol (1999) 0.75
Continuing medical education in neurology: an archives of neurology initiative. Arch Neurol (1999) 0.75
The brain code in health and disease. Arch Neurol (2000) 0.75
Encephalopathy and fatty degeneration of viscera. Lancet (1972) 0.75
Differentiation of neuroblastoma, glioma, and hybrid cells in culture as measured by the synthesis of specific protein species: evidence for neuroblast-glioblast reciprocal genetic regulation. J Neurochem (1978) 0.75
Cerebral control of speech. N Engl J Med (1968) 0.75
Accumulation of 131 I-labeled albumin in a subdural hematoma demonstrated by cisternography. J Nucl Med (1971) 0.75
Genomic medicine and the individual patient--byte to bedside: A call for papers. JAMA (2000) 0.75
Reporting clinical trials: full access to all the data. J Neurol Neurosurg Psychiatry (2002) 0.75
Reporting clinical trials: full access to all the data. Neurorehabil Neural Repair (2001) 0.75